This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In a world of podcasts , reels, and AI-written content, its fair to ask: are whitepapers still pulling their weight in pharma marketing? Once the domain of technical audiences and B2B legacy brands, whitepapers have evolved. But in 2025s fast-moving digital landscape, not all whitepapers are created equal.
A whitepaper has outlined a pathway that could allow Italy to realise the potential of digital therapeutics (DTx). The official journal of the Smith Kline Foundation, Tendenze Nuove, has published the paper entitled “Digital Therapeutics, an Opportunity for Italy” earlier this month.
Explore the key moments of truth in launch excellence for MSLs and commercial teams in this informative whitepaper. Gain valuable insights and strategies for successful launches.
WASHINGTON, February 18, 2025 PharmD Live , an innovative pharmacist-led virtual care solution powered by AI-driven algorithms, announces the release of its recent whitepaper, Maximizing Shared Savings for Payviders: ACOs, IDNs, At-Risk Provider Groups and Clinics. Download the whitepaper here.
This whitepaper provides valuable insights into the successful application of enteric polymer coatings for controlled drug delivery systems. By selecting enteric coatings, formulators can ensure the protection of their acid-sensitive APIs and create a controlled release drug delivery system.
The Transformational Value: Preparing for a Decade of Radical Change whitepaper from the Adelphi Group sets out the key tenets of the concept and the opportunity for pharma to take a big picture view of ‘transformational value’ and how to respond to it. The post Preparing for a decade of radical change in pharma appeared first on.
To learn more, download PANTHERxs latest whitepaper and SP decision-support resource: Selecting the Right Specialty Pharmacy Partner for a Successful Launch. He explains the key considerations for choosing a specialty pharmacy network design, selecting the right pharmacy partners, and establishing patient services HUBs.
The new whitepaper launched today by our publisher Cogora has laid bare the scale of the workforce crisis across general practice and explores where pharmacists sit within this. GP practices across England are struggling to recruit pharmacists because of local competition and issues related to pay, an exclusive report has suggested.
Learn how to effectively deal with fragmented data by leveraging Veeva Open Data in this informative whitepaper. Gain insights on how to streamline data management processes and improve data quality.
Name * First Last Email * Company Please tell us here if you have any other questions, and we'll be in touch shortly Submit The post Download WhitePaper: Maximizing Shared Savings for Payviders: ACOs, IDNs, At-Risk Provider Groups and Clinics appeared first on PharmD Live.
A Vizient whitepaper demonstrates how the lack of information about medication access across the supply chain is exacerbating the shortage of seven oncology drugs used to treat a multitude of cancers.
Havas Lynx Group’s 2020 whitepaper provides a blueprint for pharma brands to inject meaning into their media. The latter is the subject of our 2020 whitepaper, Media Means Business. Download the Media Means Business whitepaper today at [link]. What do we mean by ‘media’? About the author.
In GEP's latest whitepaper, explore how innovative procurement strategies are vital in overcoming challenges such as budget overruns, infrastructure readiness, and sustainability in such events. Several Middle Eastern countries are doing just that, leveraging mega-sporting events to boost tourism, infrastructure, and global branding.
This whitepaper outlines a portfolio approach combining in-house infrastructure with strategic outsourcing across ten key supply chain elements. The Hidden Costs of Building AI And How to Address Them Dnyaneshm Wed, 04/23/2025 - 23:02 In 2025, hyperscalers must scale AI faster, at lower cost, and with more flexibility.
In The Medscape Professional Networks’ latest whitepaper, Healthcare’s New Normal: COVID Speeds Shift to Digital Communications , key opinion leaders and industry experts agree that in the post-pandemic world, even as lockdowns are lifted and restrictions relaxed, the emerging trends for an increase in digital communications will stay.
The key trends for these sectors are identified and analysed in a new whitepaper from Healthware Group that offers guidance on how companies can best adjust to the new digital scenario. In the whitepaper, expert contributors share a detailed picture of the digital trends with the greatest potential to impact the near future.
A new whitepaper from 60 Seconds, Genuine Transformation: Preparing for Pharma’s New Sales Coaching Reality , looks at the recent evolution of the pharma sales function and discusses how training and coaching changed during the pandemic and how to prepare for what is coming next. This whitepaper explains how to adjust to it.
Read this whitepaper and discover how Stevanato Group can support you from start to finish. For new drug products, it is essential that pharmaceutical companies utilize the experience of container suppliers as early as possible.
Explore the latest digital health innovation applications across the patient journey, with this whitepaper by Healthinkers and EVERSANA INTOUCH. Stay informed and discover the future of healthcare technology.
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a policy paper on its strategic approach to artificial intelligence (AI). It summarises the MHRA’s view on the UK government’s whitepaper on AI regulation published in 2023.
The whitepaper Transform patient experience with intelligent hyper-personalisation examines some of the key ways in which pharma companies can transform patient experience by identifying, meeting and exceeding expectations.
Our latest whitepaper, Why Technology Is the Missing Piece in Most CSRD Compliance Plan , explores essential technologies that simplify compliance while enhancing transparency and accountability. The challenge of complicated metrics and manual processes is a familiar scene.
The new Cancer Care in Europe: Recovering from COVID-19 Disruption whitepaper assesses the disruption to patient care and the changes physicians implemented during the acute phase of the pandemic, with a focus on the way in which treatment strategies were altered.
Malaysia: Health WhitePaper The Health WhitePaper , which was first tabled in the Parliament on 14 June 2023, is a comprehensive proposal to revamp the country's healthcare system for a higher quality, more sustainable and resilient health system in stages over a 15-year period.
To learn more about how Tanner is adapting to changes in the clinical trial supply chain and embracing technological innovations, download this whitepaper.
Discover the evolving landscape of journal performance measurement with this informative whitepaper. Learn how metrics and evaluation methods are changing in the scholarly publishing industry.
This whitepaper provides valuable information for professionals in the field. Explore the latest trends and insights in the life sciences industry with Part 7 of our industry report.
This whitepaper provides in-depth analysis and key findings for industry professionals. Discover valuable insights into the rare disease landscape in Part 6 of our Life Sciences Industry Report.
Explore the latest update on the World Without Disease initiative in 2024 with our comprehensive whitepaper. Discover the progress, challenges, and future prospects of this groundbreaking global health initiative.
Explore the latest update on the World Without Disease initiative in 2024 with our comprehensive whitepaper. Discover the progress, challenges, and future prospects of this groundbreaking global health initiative.
The deal comes shortly after the publication of a whitepaper that laid out a framework that could be adopted by Italy to realise the potential of DTx, including the creation of a reimbursement pathway similar to that set up in Germany. .
In this whitepaper Pfizer CentreOne examines what developers and their manufacturing partners need to know about its unique regulatory challenges and how to navigate HPOSD’s complex manufacturing environment successfully.
In this whitepaper, Pfizer CentreOne discusses how a small or medium sized biotech or pharma company can benefit from the experience and assistance provided by a CDMO.
In this whitepaper, learn how a SaaS-based LIMS modernization program optimizes data management, fosters collaboration, and improves decision-making to stay at the forefront of scientific innovation. As today’s labs continue to evolve, the software solutions that support them must too.
This whitepaper from Jubilant HollisterStier discusses the range of factors to consider when outsourcing manufacturing for aseptically filled and terminally sterilized products. Vetting a CMO for sterile injectable fill finish means more than capacity and equipment.
In this whitepaper, learn how a platform approach to scientific data management, including semantic search, advanced analytics, and lab automation, leads to better enterprise decisions at the executive level, optimized lab performance, more discoveries, and stronger product pipelines.
This GEP-Procurement Leaders whitepaper — Embedded AI: The Catalyst for Technological Change — outlines how procurement professionals are using AI-driven data preparation and analysis tools to achieve better outcomes. But that requires a ton of IT resources. Or does it?
52
52
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content